Pancreatic Cancer

Show only recruiting trials?

Roche.png

SSP-20-006
(SALTKIVA)

A Phase 2 Study of Saltikva (Attenuated Salmonella Typhimurium Containing the Human Gene for Interleukin-2) in Patients With Metastatic Pancreatic Cancer

Status

Recruiting

JCP

JCP089

NCT

NCT04589234

Roche.png

OZM-101 | NeoPancOne

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma (NeoPancOne)

Status

Opening Soon

JCP

Pending

NCT

NCT04472910

Roche.png

PA.6

Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma

Status

Closed to Accrual

JCP

PA.6

NCT

NCT01526135

Roche.png

PA.7

A Randomized Phase II Trial of Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma

Status

Closed to Accrual

JCP

PA.7

NCT

NCT02879318

Filter Clinical Trials by:

arrow&v
arrow&v
arrow&v
arrow&v

Biomarkers:

No trials match your search criteria